A Classification Based on Peak Systolic Velocity and End Diastolic Velocity Predicts Sildenafil Citrate Success

Scandinavian Journal of Urology and Nephrology

Volumn 37, Issue 6, 2003, Pages 502-506

  Basar, M Murad ^a,c   Atari, Ali ^b   Tekdogan, Ümit Y ^b   Batislam, Ertan ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Arterial insufficiency; Erectile dysfunction; Penile Doppler ultrasonography; Sildenafil; Veno occlusive disease

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; ERECTILE DYSFUNCTION; EVALUATION; FOLLOW UP; HEADACHE; HEART PALPITATION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATHOLOGY; PENIS ERECTION; PREDICTION; PRIORITY JOURNAL; SIDE EFFECT; SWEATING; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; VASCULAR DISEASE; VEIN OCCLUSION; VELOCITY; VISUAL DISORDER;

ADMINISTRATION, ORAL; ADULT; AGED; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; PENIS; PIPERAZINES; PROBABILITY; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 0347126344     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590310014526     Document Type: Article

References (21)

1. Feldman HA, Goldstein I, Hatzichristau DG, Krane RJ, Mc Kinlay JB. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
2. Lue TF. Erectile dysfunction. N Engl J Med 2000; 342: 1802-13.
3. Hsieh JT, Lue TF, Muller SC. The influence of blood flow and blood pressure on penile erection. Int J Impot Res 1989; 1: 35-42.
4. Lue TF, Hricak H, Marich KW, Tanagho EA. Vasculo-genic impotence evaluated by high-resolution ultrasonography and pulsed Doppler analysis. Radiology 1985; 155: 777-81.
5. Meuleman EJ, Diemont WL. Investigation of erectile dysfunction: diagnostic testing for vascular factors in erectile dysfunction. Urol Clin North Am 1995; 22: 803-19.
6. Lue TF, Broderick G. Evaluation and nonsurgical treatment of erectile dysfunction and priapism. In: Walsh PC, Retik AB, Vaughan ED Jr, Weia AJ, eds. Campbell's urology, 17th edn., Vol. 2. Philadelphia, PA: Saunders, 1998: 1181-214.
7. Montague DK, Barada JH, Belker AM, Levine LA, Nadig PW, Roerborn CG, et al. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. The American Urological Association. J Urol 1996; 156: 2007-11.
8. Jarow JP, Nana-Sinkam P, Sabbagh M, Eskew A. Outcome analysis of goal directed therapy for impotence. J Urol 1996; 155: 1609-12.
9. Padma-Nathan H, Guiliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am 2001; 28: 321-34.
10. Ralph D, McNicholas T. UK management guidelines for erectile dysfunction. Br Med J 2000; 321: 499-503.
11. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile function. Urology 1997; 49: 822-30.
12. Patel U, Amin Z, Freidman E, Vale J, Kirby RW, Lees WR. Colour flow and spectral Doppler imaging after papaverine-induced penile erection in 220 impotent men: study of temporal patterns and the importance of repeated sampling, velocity asymmetry and vascular anomalies. Clin Radiol 1993; 48: 18-24.
13. Mancini M, Bartolini M, Maggi M, Innocenti P, Villari N, Forti G. Duplex ultrasound evaluation of cavernosal peak velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl 2000; 23: 199-204.
14. Montorsi F, Guazzoni G, Barbieri L, Ferini-Strambi L, Iannaccone S, Calori G, et al. Genital plus audiovisual sexual stimulation following intracavernous vasoactive injection versus re-dosing for erectile dysfunction-results of a prospective study. J Urol 1998; 159: 120-1.
15. Erdogru T, Kadioglu A, Cayan S, Tellaloglu S. Does the positive intracavernous papaverine test always indicate a normal penile vascular system? Eur Urol 1997; 31: 323-8.
16. Rahman MA. Pathophysiology of erectile dysfunction. In: Vaughan ED Jr, Perlmutter AP, eds. Atlas of clinical urology, Vol. 1. Philadelphia, PA: Current Medicine Inc, 1999: 1-16.
17. Jarow JP, Burnett AL, Geringer AM. Clinical efficacy of sildenafil citrate based on aetiology and response to prior treatment. J Urol 1999; 162: 722-5.
18. Lewis R, Bennett CJ, Borkon WD, Boykin WH, Althof SE, Stecher VJ, et al. Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire. Urology 2001; 57: 960-5.
19. Sairam K, Kulinskaya E, Hanbury D, Boustead G, McNicholas T. Oral sildenafil (Viagra trademark) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospital. BMC Urol 2002; 2: 4-11.
20. Basar M, Tekdogan UY, Yilmaz E, Basar H, Atan A, Batislam E. The efficacy of sildenafil in different aetiologies of erectile dysfunction. Int Urol Nephrol 2001; 32: 403-7.
21. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397-404.